- US-listed companies
- PTC THERAPEUTICS, INC.
- Balance sheet
PTC THERAPEUTICS, INC.PTCT
Market cap
$5.9B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 15 | 50 | 58 | 58 | 112 | 169 | 296 | 216 | 197 | 296 | 610 | 795 |
| Marketable securities, current | 127 | 265 | 281 | 173 | 79 | 58 | 399 | 895 | 584 | 131 | 283 | 360 |
| Total cash & short-term investments | 142 | 315 | 339 | 232 | 191 | 228 | 694 | 1,111 | 781 | 427 | 893 | 1,155 |
| Inventories | - | - | - | - | 11 | 16 | 19 | 19 | 16 | 22 | 31 | 23 |
| Total current assets | 145 | 324 | 356 | 261 | 249 | 321 | 779 | 1,232 | 954 | 694 | 1,219 | 1,366 |
| Property, plant and equipment, net | 7 | 9 | 9 | 7 | 8 | 13 | 22 | 34 | 53 | 73 | 87 | 61 |
| Total non-current assets | 7 | 10 | 12 | 8 | 143 | 798 | 844 | 977 | 984 | 1,012 | 677 | 339 |
| Total assets | 152 | 333 | 368 | 269 | 392 | 1,119 | 1,624 | 2,208 | 1,938 | 1,706 | 1,896 | 1,705 |
| Long-term debt, current | 48,622 | - | - | - | - | 12 | 20 | - | 150 | - | - | - |
| Total current liabilities | 13 | 32 | 45 | 50 | 82 | 167 | 236 | 277 | 509 | 406 | 603 | 581 |
| Long-term debt, non-current | - | - | 95 | 98 | 145 | 141 | 294 | 309 | 282 | 572 | 284 | 285 |
| Total non-current liabilities | 2 | 2 | 97 | 100 | 153 | 602 | 794 | 1,449 | 1,427 | 1,646 | 2,111 | 2,222 |
| Total liabilities | 15 | 35 | 142 | 150 | 235 | 768 | 1,029 | 1,726 | 1,937 | 2,053 | 2,714 | 2,803 |
| Common stock and paid-in capital | 465 | 722 | 820 | 856 | 967 | 1,288 | 1,795 | 2,172 | 2,124 | 2,305 | 2,466 | 2,575 |
| Retained earnings | -328,798,293 | -423 | -593 | -735 | -814 | -939 | -1,190 | -1,629 | -2,098 | -2,657 | -3,284 | -3,647 |
| Stockholders' equity | 137 | 298 | 226 | 120 | 156 | 351 | 594 | 482 | 1 | -347 | -819 | -1,098 |
| Total debt | 49,000 | - | 92 | 98 | 145 | 153 | 314 | 309 | 431 | 572 | 284 | 285 |
| Net debt | -142,418,403 | - | -247 | -133 | -46 | -75 | -380 | -802 | -349 | 145 | -609 | -870 |
| D/E ratio (%) | 0 | - | 40.6 | 82.1 | 92.7 | 43.6 | 52.8 | 64.1 | 30,002.4 | -164.7 | -34.7 | -26 |